Susanne has more than 11 years of experience in market access consulting and delivering measurable business results in new product development and repositioning products on the market. Her projects include clinical trial assessment, payer positioning, value strategy and pricing strategy. She has worked with the top 10 pharmaceutical companies for a broad range of indications to deliver targeted strategic advice on market access positioning.
Prior to joining Evidera, Susanne worked for the Ministry of Health in Berlin, then joined the Department of Health in England where she was a strategy policy leader for two years when the National Institute for Health and Care Excellence was established. She led the European Health Policy Research Institute at PricewaterhouseCoopers and also was an associate director at THS, a specialized market access and pricing and reimbursement consulting company.
In addition, Susanne formerly led European market access as vice president at Kantar Health and was responsible for business development, engaging with payer bodies and developing new service offerings. Her expertise includes hepatitis C virus, oncology, psychiatric conditions and diabetes.
Susanne holds an MD and a master’s in business strategy from the London School of Economics and Political Science. Her country experience includes Europe, Australia, Russia and Brazil.